Omega Tots Long Term Follow-up

NAEnrolling by invitationINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 25, 2024

Study Completion Date

June 30, 2026

Conditions
Preterm BirthChild Development
Interventions
DRUG

Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)

200 mg DHA+ 200 mg AA per day for 6 months

DIETARY_SUPPLEMENT

Placebo

400 mg corn oil per day for 6 months

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Sarah Keim

OTHER